Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 506

1.

Adjusted Troponin I for Improved Evaluation of Patients with Chest Pain.

Boeckel JN, Palapies L, Klotsche J, Zeller T, von Jeinsen B, Perret MF, Kleinhaus SL, Pieper L, Tzikas S, Leistner D, Bickel C, Stalla GK, Lehnert H, Lindahl B, Wittchen HU, Silber S, Baldus S, Maerz W, Dimmeler S, Blankenberg S, Münzel T, Zeiher AM, Keller T.

Sci Rep. 2018 May 24;8(1):8087. doi: 10.1038/s41598-018-26120-1.

2.

The varicocele argument resurfaces.

Silber S.

J Assist Reprod Genet. 2018 Jun;35(6):1079-1082. doi: 10.1007/s10815-018-1160-2. Epub 2018 Mar 27.

PMID:
29589295
3.

In Reply.

Albus C, Barkhausen J, Fleck E, Haasenritter J, Lindner O, Silber S.

Dtsch Arztebl Int. 2018 Feb 23;115(8):131-132. doi: 10.3238/arztebl.2018.0131c. No abstract available.

4.

[Do you know your risk of getting a heart attack?]

Silber S.

MMW Fortschr Med. 2018 Mar;160(4):38-44. doi: 10.1007/s15006-018-0243-4. Review. German. No abstract available.

PMID:
29508323
5.

Longitudinal change instead of baseline testosterone predicts depressive symptoms.

Kische H, Pieper L, Venz J, Klotsche J, März W, Koch-Gromus U, Pittrow D, Lehnert H, Silber S, Stalla GK, Zeiher AM, Wittchen HU, Haring R.

Psychoneuroendocrinology. 2018 Mar;89:7-12. doi: 10.1016/j.psyneuen.2017.12.013. Epub 2017 Dec 21.

PMID:
29306775
6.

The Diagnosis of Chronic Coronary Heart Disease.

Albus C, Barkhausen J, Fleck E, Haasenritter J, Lindner O, Silber S.

Dtsch Arztebl Int. 2017 Oct 20;114(42):712-719. doi: 10.3238/arztebl.2017.0712.

7.

Efficacy and Safety of a Single-Dose Mebendazole 500 mg Chewable, Rapidly-Disintegrating Tablet for Ascaris lumbricoides and Trichuris trichiura Infection Treatment in Pediatric Patients: A Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study.

Silber SA, Diro E, Workneh N, Mekonnen Z, Levecke B, Steinmann P, Umulisa I, Alemu H, Baeten B, Engelen M, Hu P, Friedman A, Baseman A, Mrus J.

Am J Trop Med Hyg. 2017 Dec;97(6):1851-1856. doi: 10.4269/ajtmh.17-0108. Epub 2017 Aug 31.

8.

Corrigendum to 'Live birth derived from oocyte spindle transfer to prevent mitochondrial disease': [Reproductive BioMedicine Online 34 (2017) 361-368].

Zhang J, Liu H, Luo S, Lu Z, Chávez-Badiola A, Liu Z, Yang M, Merhi Z, Silber SJ, Munné S, Konstantinidis M, Wells D, Tang JJ, Huang T.

Reprod Biomed Online. 2017 Dec;35(6):750. doi: 10.1016/j.rbmo.2017.07.008. Epub 2017 Jul 20. No abstract available.

PMID:
28943159
9.

Unraveling transcriptome dynamics in human spermatogenesis.

Jan SZ, Vormer TL, Jongejan A, Röling MD, Silber SJ, de Rooij DG, Hamer G, Repping S, van Pelt AMM.

Development. 2017 Oct 15;144(20):3659-3673. doi: 10.1242/dev.152413. Epub 2017 Sep 21.

10.

Corrigendum to 'Ovarian function 6 years after cryopreservation and transplantation of whole sheep ovaries' [Reproductive BioMedicine Online 34 (2010) 48-52.

Arav A, Gavish Z, Elami A, Natan Y, Revel A, Silber S, Gosden RG, Patrizio P.

Reprod Biomed Online. 2017 Dec;35(6):751. doi: 10.1016/j.rbmo.2017.08.021. Epub 2017 Sep 5. No abstract available.

PMID:
28923413
11.

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial.

Ory DS, Ottinger EA, Farhat NY, King KA, Jiang X, Weissfeld L, Berry-Kravis E, Davidson CD, Bianconi S, Keener LA, Rao R, Soldatos A, Sidhu R, Walters KA, Xu X, Thurm A, Solomon B, Pavan WJ, Machielse BN, Kao M, Silber SA, McKew JC, Brewer CC, Vite CH, Walkley SU, Austin CP, Porter FD.

Lancet. 2017 Oct 14;390(10104):1758-1768. doi: 10.1016/S0140-6736(17)31465-4. Epub 2017 Aug 10.

PMID:
28803710
12.

Efficacy of single-dose 500 mg mebendazole in soil-transmitted helminth infections: a review.

Mrus J, Baeten B, Engelen M, Silber SA.

J Helminthol. 2018 May;92(3):269-278. doi: 10.1017/S0022149X17000426. Epub 2017 Jul 18.

PMID:
28716158
13.

Improved risk stratification in prevention by use of a panel of selected circulating microRNAs.

Keller T, Boeckel JN, Groß S, Klotsche J, Palapies L, Leistner D, Pieper L, Stalla GK, Lehnert H, Silber S, Pittrow D, Maerz W, Dörr M, Wittchen HU, Baumeister SE, Völker U, Felix SB, Dimmeler S, Zeiher AM.

Sci Rep. 2017 Jul 3;7(1):4511. doi: 10.1038/s41598-017-04040-w.

14.

Corrigendum to 'Live birth derived from oocyte spindle transfer to prevent mitochondrial disease' [Reproductive BioMedicine Online 34 (2017) 361-368].

Zhang JJ, Liu H, Luo S, Lu Z, Chávez-Badiola A, Liu Z, Yang M, Merhi Z, Silber SJ, Munné S, Konstantinidis M, Wells D, Huang T.

Reprod Biomed Online. 2017 Jul;35(1):49. doi: 10.1016/j.rbmo.2017.04.002. Epub 2017 May 8. No abstract available.

PMID:
28495440
15.

Use of Electronic Clinical Decision Support and Hard Stops to Decrease Unnecessary Thyroid Function Testing.

Dalal S, Bhesania S, Silber S, Mehta P.

BMJ Qual Improv Rep. 2017 Apr 28;6(1). pii: u223041.w8346. doi: 10.1136/bmjquality.u223041.w8346. eCollection 2017.

16.

Intrinsic fertility of human oocytes.

Silber SJ, Kato K, Aoyama N, Yabuuchi A, Skaletsky H, Fan Y, Shinohara K, Yatabe N, Kobayashi T.

Fertil Steril. 2017 May;107(5):1232-1237. doi: 10.1016/j.fertnstert.2017.03.014. Epub 2017 Apr 19.

17.

Chapter 13 Human Ovarian Tissue Vitrification.

Silber S.

Methods Mol Biol. 2017;1568:177-194. doi: 10.1007/978-1-4939-6828-2_13.

PMID:
28421497
18.

Live birth derived from oocyte spindle transfer to prevent mitochondrial disease.

Zhang J, Liu H, Luo S, Lu Z, Chávez-Badiola A, Liu Z, Yang M, Merhi Z, Silber SJ, Munné S, Konstantinidis M, Wells D, Tang JJ, Huang T.

Reprod Biomed Online. 2017 Apr;34(4):361-368. doi: 10.1016/j.rbmo.2017.01.013. Erratum in: Reprod Biomed Online. 2017 Jul;35(1):49. Konstandinidis, Michalis [corrected to Konstantinidis, Michalis]. Erratum in: Reprod Biomed Online. 2017 Dec;35(6):750.

PMID:
28385334
19.

[Suspected stable coronary artery disease - When should the general practitioner refer to a cardiologist for further evaluation and/or cardiac catheterization?]

Silber S.

MMW Fortschr Med. 2017 Mar;159(5):46-48. doi: 10.1007/s15006-017-9388-9. Review. German. No abstract available.

PMID:
28321727
20.

[Secondary prevention after myocardial infarction with prolonged dual anti-platelet therapy (DAPT). A new therapeutic concept].

Silber S.

MMW Fortschr Med. 2017 Mar;159(5):49-52. doi: 10.1007/s15006-017-9389-8. Review. German. No abstract available.

PMID:
28321726
21.

5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent: The RESOLUTE Global Clinical Trial Program.

Yeh RW, Silber S, Chen L, Chen S, Hiremath S, Neumann FJ, Qiao S, Saito S, Xu B, Yang Y, Mauri L.

JACC Cardiovasc Interv. 2017 Feb 13;10(3):247-254. doi: 10.1016/j.jcin.2016.11.004. Epub 2017 Jan 18.

22.

9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System.

Cutlip DE, Garratt KN, Novack V, Barakat M, Meraj P, Maillard L, Erglis A, Jauhar R, Popma JJ, Stoler R, Silber S; PzF SHIELD Trial Investigators.

JACC Cardiovasc Interv. 2017 Jan 23;10(2):160-167. doi: 10.1016/j.jcin.2016.10.037.

23.

Clean, Intermittent Self-Catheterization in the Treatment of Urinary Tract Disease.

Lapides J, Diokno AC, Silber SJ, Lowe BS.

J Urol. 2017 Feb;197(2S):S122-S124. doi: 10.1016/j.juro.2016.10.097. Epub 2016 Dec 21. No abstract available.

PMID:
28012758
24.
25.

Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial.

Fajadet J, Neumann FJ, Hildick-Smith D, Petronio S, Zaman A, Spence M, Wöhrle J, Elhadad S, Roberts D, Hovasse T, Valdés M, Silber S.

EuroIntervention. 2017 Jan 20;12(13):1595-1604. doi: 10.4244/20150112-07.

26.

Improving IVF: is there a limit to our ability to manipulate human biology?

Patrizio P, Silber S.

J Assist Reprod Genet. 2017 Jan;34(1):7-9. doi: 10.1007/s10815-016-0828-8. Epub 2016 Oct 28. No abstract available.

27.

Ovarian tissue cryopreservation and transplantation: scientific implications.

Silber S.

J Assist Reprod Genet. 2016 Dec;33(12):1595-1603. Epub 2016 Oct 8. Review.

28.

Corrigendum: Parallel evolution of male germline epigenetic poising and somatic development in animals.

Lesch BJ, Silber SJ, McCarrey JR, Page DC.

Nat Genet. 2016 Sep 28;48(10):1296. doi: 10.1038/ng1016-1296b. No abstract available.

PMID:
27681290
29.

[Consensus statement: Management of oral anticoagulation for stroke prevention in patients with nonvalvular atrial fibrillation].

Helms TM, Silber S, Schäfer A, Masuhr F, Palm F, Darius H, Schrör K, Bänsch D, Bramlage P, Hankowitz J, Karle CA, Stargardt T, Weil J, Geller JC.

Herzschrittmacherther Elektrophysiol. 2016 Sep;27(3):295-306. doi: 10.1007/s00399-016-0447-1. Review. German.

PMID:
27576696
30.

Parallel evolution of male germline epigenetic poising and somatic development in animals.

Lesch BJ, Silber SJ, McCarrey JR, Page DC.

Nat Genet. 2016 Aug;48(8):888-94. doi: 10.1038/ng.3591. Epub 2016 Jun 13. Erratum in: Nat Genet. 2016 Sep 28;48(10):1296.

PMID:
27294618
31.

Effect of Diabetes Mellitus on Frequency of Adverse Events in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention.

Piccolo R, Franzone A, Koskinas KC, Räber L, Pilgrim T, Valgimigli M, Stortecky S, Rat-Wirtzler J, Silber S, Serruys PW, Jüni P, Heg D, Windecker S.

Am J Cardiol. 2016 Aug 1;118(3):345-52. doi: 10.1016/j.amjcard.2016.05.005. Epub 2016 May 14.

PMID:
27289296
32.

Evaluation of the diagnostic potential of urinary N-Acetyltyramine-O,β-glucuronide (NATOG) as diagnostic biomarker for Onchocerca volvulus infection.

Lagatie O, Njumbe Ediage E, Batsa Debrah L, Diels L, Nolten C, Vinken P, Debrah A, Dillen L, Silber S, Stuyver LJ.

Parasit Vectors. 2016 May 23;9(1):302. doi: 10.1186/s13071-016-1582-6.

33.

Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.

Pilgrim T, Vranckx P, Valgimigli M, Stefanini GG, Piccolo R, Rat J, Rothenbühler M, Stortecky S, Räber L, Blöchlinger S, Hunziker L, Silber S, Jüni P, Serruys PW, Windecker S.

Am Heart J. 2016 May;175:56-65. doi: 10.1016/j.ahj.2016.01.021. Epub 2016 Feb 23.

PMID:
27179724
34.

A case report of the new Polyzene™-F COBRA PzF™ Nanocoated Coronary Stent System (NCS): Addressing an unmet clinical need.

Styllou P, Silber S.

Cardiovasc Revasc Med. 2016 Apr-May;17(3):209-11. doi: 10.1016/j.carrev.2016.01.007. Epub 2016 Jan 22.

35.

How ovarian transplantation works and how resting follicle recruitment occurs: a review of results reported from one center.

Silber S.

Womens Health (Lond). 2016;12(2):217-27. doi: 10.2217/whe.15.108. Epub 2016 Feb 22.

36.

Impact of Diabetic Status on Outcomes After Revascularization With Drug-Eluting Stents in Relation to Coronary Artery Disease Complexity: Patient-Level Pooled Analysis of 6081 Patients.

Koskinas KC, Siontis GC, Piccolo R, Franzone A, Haynes A, Rat-Wirtzler J, Silber S, Serruys PW, Pilgrim T, Räber L, Heg D, Jüni P, Windecker S.

Circ Cardiovasc Interv. 2016 Feb;9(2):e003255. doi: 10.1161/CIRCINTERVENTIONS.115.003255.

37.

Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease: A Patient-Level Pooled Analysis of 6,081 Patients.

Piccolo R, Pilgrim T, Heg D, Franzone A, Rat-Wirtzler J, Räber L, Silber S, Serruys PW, Jüni P, Windecker S.

JACC Cardiovasc Interv. 2015 Nov;8(13):1657-66. doi: 10.1016/j.jcin.2015.08.013.

38.

Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program.

Abdel-Wahab M, Neumann FJ, Serruys P, Silber S, Leon M, Mauri L, Yeung A, Belardi JA, Widimský P, Meredith I, Saito S, Richardt G.

EuroIntervention. 2016 Jul 20;12(4):465-72. doi: 10.4244/EIJY15M07_07.

39.

Unifying theory of adult resting follicle recruitment and fetal oocyte arrest.

Silber S.

Reprod Biomed Online. 2015 Oct;31(4):472-5. doi: 10.1016/j.rbmo.2015.06.022. Epub 2015 Jul 15.

40.

TEX11 is mutated in infertile men with azoospermia and regulates genome-wide recombination rates in mouse.

Yang F, Silber S, Leu NA, Oates RD, Marszalek JD, Skaletsky H, Brown LG, Rozen S, Page DC, Wang PJ.

EMBO Mol Med. 2015 Sep;7(9):1198-210. doi: 10.15252/emmm.201404967.

41.

Comparison of zotarolimus- and everolimus-eluting coronary stents: final 5-year report of the RESOLUTE all-comers trial.

Iqbal J, Serruys PW, Silber S, Kelbaek H, Richardt G, Morel MA, Negoita M, Buszman PE, Windecker S.

Circ Cardiovasc Interv. 2015 Jun;8(6):e002230. doi: 10.1161/CIRCINTERVENTIONS.114.002230.

42.

Fresh and cryopreserved ovary transplantation and resting follicle recruitment.

Silber S, Pineda J, Lenahan K, DeRosa M, Melnick J.

Reprod Biomed Online. 2015 Jun;30(6):643-50. doi: 10.1016/j.rbmo.2015.02.010. Epub 2015 Feb 27.

PMID:
25892498
43.

Stentvergleich bei KHK: Vollständig absorbierbare Stents bringen keinen gesicherten Vorteil.

Silber S.

Dtsch Med Wochenschr. 2015 Mar;140(6):386. doi: 10.1055/s-0041-100940. Epub 2015 Mar 16. German. No abstract available.

PMID:
25774723
44.

Live birth rates after MESA or TESE in men with obstructive azoospermia: is there a difference?

van Wely M, Barbey N, Meissner A, Repping S, Silber SJ.

Hum Reprod. 2015 Apr;30(4):761-6. doi: 10.1093/humrep/dev032. Epub 2015 Mar 3.

PMID:
25740877
45.

Fertility preservation for age-related fertility decline - authors' reply.

Stoop D, Silber S, Cobo A.

Lancet. 2015 Feb 7;385(9967):507-8. doi: 10.1016/S0140-6736(15)60200-8. No abstract available.

PMID:
25705841
46.

Impact of body mass index on long-term clinical outcomes after second-generation drug eluting stent implantation: Insights from the international global RESOLUTE program.

Diletti R, Garcia-Garcia HM, Bourantas C, Van Mieghem NM, van Geuns RJ, Muramatsu T, Zhang YJ, Mauri L, Belardi J, Silber S, Widimsky P, Leon M, Windecker S, Meredith I, Neumann FJ, Yeung AC, Saito S, Liu M, van Leeuwen F, Serruys PW.

Catheter Cardiovasc Interv. 2015 May;85(6):952-8. doi: 10.1002/ccd.25828. Epub 2015 Feb 17.

PMID:
25689692
47.

Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial.

Dudek D, Dziewierz A, Brener SJ, Abizaid A, Merkely B, Costa RA, Bar E, Rakowski T, Kornowski R, Dressler O, Abizaid A, Silber S, Stone GW.

Circ Cardiovasc Interv. 2015 Feb;8(2):e001484. doi: 10.1161/CIRCINTERVENTIONS.114.001484.

48.

Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial.

Chevalier B, Wijns W, Silber S, Garcia E, Serra A, Paunovic D, Serruys P; NOBORI 1 investigators.

EuroIntervention. 2015 Sep;11(5):549-54. doi: 10.4244/EIJY14M12_13.

49.

The effectiveness of the cardiovascular disease prevention programme 'KardioPro' initiated by a German sickness fund: a time-to-event analysis of routine data.

Witt S, Leidl R, Becker C, Holle R, Block M, Brachmann J, Silber S, Stollenwerk B.

PLoS One. 2014 Dec 8;9(12):e114720. doi: 10.1371/journal.pone.0114720. eCollection 2014.

50.

Three-year outcomes of percutaneous coronary intervention with next-generation zotarolimus-eluting stents for de novo coronary bifurcation lesions.

Ferenc M, Kornowski R, Belardi J, Serruys P, Silber S, Widimský P, Windecker S, Neumann FJ.

J Invasive Cardiol. 2014 Dec;26(12):630-8.

Supplemental Content

Loading ...
Support Center